Still preclinical so don't get too ex... - Advanced Prostate...

Advanced Prostate Cancer

21,446 members26,866 posts

Still preclinical so don't get too excited: Lu-177 Lu-lbu-DAB-PSMA works better than Lu-177-PSMA-617

Maxone73 profile image
2 Replies

From Sweden with love...and hopefully with a clinical trial soon

"The data of this study demonstrated a significant therapeutic advantage of [Lu-177]Lu-Ibu-DAB-PSMA over [Lu-177]Lu-PSMA-617 and a more favorable safety profile as compared to that of [Lu-177]Lu-PSMA-ALB-56. Based on these results, [Lu-177]Lu-Ibu-DAB-PSMA may have the potential for a clinical translation."

gup.ub.gu.se/publication/31...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...
2 Replies
Leader4077 profile image
Leader4077

Is that dosage available anywhere in the US? Also, do insurance companies cover the cost yet? Lu-PSMA-617 has been around a long time and is covered by most insurances.

Maxone73 profile image
Maxone73 in reply to Leader4077

It’s still preclinical so not tested on humans yet

You may also like...

First clinical trial of Lu-177-PSMA-617 in recurrent, hormone-sensitive men

a pilot trial: https://www.prostatecancer.news/2021/04/first-clinical-trial-of-lu-177-psma-617.html

New Trial of Lu-177-PSMA-617 to begin April 30, 2021.

new multi-institutional randomized clinical trial of Lu-177-PSMA-617 that is scheduled to begin...

New Phase 1b (NON-randomized, dose timing) trial of Lu-177-PSMA-617 + Keytruda at UCSF announced

still hormone sensitive. There is a single Lu-177-PSMA-617 infusion and patients will get the...

New randomized clinical trial of Lu-177-PSMA-617 for men who are still hormone sensitive

chemo: https://clinicaltrials.gov/ct2/show/NCT04689828 A full list of all current US clinical...

Lu-177-PSMA-617 vs Jevtana (cabazitaxel): which should I do next?

Lu-177-PSMA-617 seems to beat Jevtana in a randomized clinical trial. In those countries where it is